
News|Articles|April 2, 2005
- Pharmaceutical Technology-04-02-2005
- Volume 29
- Issue 4
Using Visible Residue Limits for Introducing New Compounds into a Pharmaceutical Research Facility
An increasing number of new compounds are being introduced into pharmaceutical pilot plants.The knowledge base for these compounds regarding their toxicities,physical handling, and cleaning is limited.The authors examine various approaches for addressing the cleaning validation of new compounds and discuss the role of determining appropriate visible residue limits.
Advertisement
Articles in this issue
almost 21 years ago
April 2005almost 21 years ago
Management Controls for GMP Compliancealmost 21 years ago
The Sector Chart: A New Engineering Graph for Pharmaceutical Processesalmost 21 years ago
PAT and Process Understanding: A Call to Armsalmost 21 years ago
Cold Chain Concernsalmost 21 years ago
Evolutions in Direct Compressionalmost 21 years ago
X-ray Microtomography of Solid Dosage Formsalmost 21 years ago
Orient ExpressNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Navigating AI, Sustainability, and Operational Resilience
2
Integrating AI and Machine Learning in Drug Discovery and Development
3
Pharmaceutical Supply Chain Resilience in a Shifting Market
4
SÜDPACK Medica to Unveil Next-Generation Sustainable Packaging and Streamlined Services at Pharmapack Europe 2026
5




